Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease

doi 10.1101/817106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

In Vivo Dopamine Transporter Imaging in a Unilateral 6-Hydroxydopamine Rat Model of Parkinson Disease Using 11c-Methylphenidate PET

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

Gene Therapy for Parkinson Disease(Parkinson Disease)

Japanese Journal of Neurosurgery
SurgeryNeurology
2006English

Proteomic Analysis of Rat Brain Mitochondria Following Exposure to Dopamine Quinone: Implications for Parkinson Disease

Neurobiology of Disease
Neurology
2008English

Hippocampal Abnormalities and Memory Deficits in Parkinson Disease: A Multimodal Imaging Study

Neurology
Neurology
2012English

Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18f]-Dopa PET Imaging Study

American Journal of Psychiatry
PsychiatryMental Health
2011English

In Vivo Imaging as a Pharmacodynamic Marker

Clinical Cancer Research
Cancer ResearchOncology
2014English

Binding Capacity: Cooperativity and Buffering in Biopolymers.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1988English

Dopamine Transporter Imaging Assessment of Parkinson's Disease Progression

2000English

Transcranial Sonography and Functional Imaging in Glucocerebrosidase Mutation Parkinson Disease

Parkinsonism and Related Disorders
GerontologyGeriatricsNeurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy